4T1-hHER2-Luc
Strain Information
Validation Data
Fig1. HER2 expression in 4T1-hHER2 cell lines.
Fig2. In vivo validation of 4T1-hHER2 in BALB/c mice.
BALB/c mice were inoculated with 4T1-hHER2 subcutaneously at 1×106 cells/mouse inoculum for tumor development.
Fig3. HER2 expression in tumors after in vivo growth of 4T1-hHER2 in wild type BALB/c mice.
The tumors were collected at day 34 post tumor cell inoculation.
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
